Reimagine the future of your safety with Asphalion as your partner
Unsure where to begin with digital solutions? Let Asphalion take the lead!
We offer cutting-edge, validated software solutions to streamline your digital transformation efficiently and effectively.
AsphaSearch
AsphaAlerts
AsphaDigiMedia
Unlocking Active Listening: Asphalion’s AI-Powered Social Media Screening!
Join the digital wave and revolutionize your Pharmacovigilance strategy with Asphalion!
- Experience innovation, reliability, and excellence
- Most-innovate technology on the market: AI validated tools
- Centralize your safety activities in one place
- Validated technology led by the highest quality standards
- Effective, budget & time saving resources
Sonia López
Pharmacovigilance Director
European Qualified Person Responsible for Pharmacovigilance.
She holds a Pharmacy Degree from the University of Barcelona and a Master’s Degree in Pharmacovigilance and Post-Authorization Studies from the University of Sevilla.
With over 25 years of expertise in the pharmaceutical industry, Sonia has fulfilled various roles, including overseeing the Pharmacovigilance system of medicinal products, Post-Marketing Surveillance System of Medical Devices, and their Quality Systems for several companies and their international partner networks. She has also served as the EU-QPPV and local QPPV for multiple companies.
In addition to her professional responsibilities, Sonia serves as the Manager and Coordinator of the Scientific Committee of Pharmacovigilance of the Spanish Association of Industry Pharmacists (AEFI) and has collaborated with Spanish competent authorities in developing Good Pharmacovigilance Practices.
Laura Eder
Associate Director
of Asphalion’s Pharmacovigilance Department
With a PhD in Biomedical Research from the University of Navarra, Laura has earned distinction with Cum Laude honors by unanimity and the mention of European Doctor. Her educational background encompasses Biology & Biochemistry, along with a Master’s Degree in Health Administration. Laura brings extensive experience in Biomedical Research from both national and international research laboratories, as well as expertise as an Assistant Professor in General Genetics and Human Genetics.
Laura possesses a robust understanding of Pharmacovigilance and Health Product Surveillance, acquired through her roles in the pharmaceutical industry and scientific consultancy. She has served as EU-QPPV, Deputy or Local QPPV, and Deputy for third-party companies, in addition to conducting Pharmacovigilance Audits, Medical Writing, and various Pharmacovigilance activities.
“At Asphalion, we continually strive to stay ahead of the curve by embracing the latest trends. In this spirit, we are firmly committed to implementing digital tools that enhance our processes, boost our efficiency, and uphold the highest standards of quality for our clients.
Our Pharmacovigilance department spearheads our digitalization efforts, leading the way in integrating innovative tools into routine pharmacovigilance activities. This proactive approach ensures that our clients gain a significant competitive advantage, receiving unparalleled added value in their Pharmacovigilance activities.
We take pride in being your trusted partner in the digital age. Together, we are setting new benchmarks in patient safety and care, driving innovation, and delivering excellence every step of the way”
